Antibiotic resistance continues to push modern medicine into dangerous territory. In hospitals around the world, infections ...
In a new study, researchers show how so‑called TriPcides can target the bacterium Staphylococcus aureus, including antibiotic‑resistant strains such as MRSA. The compounds disrupt the bacteria's ...
Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...
Deaths from Staphylococcus aureus–associated lower respiratory tract infections tripled from 1990 to 2021 worldwide.
A new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An ...
Staphylococcus aureus is a versatile Gram-positive bacterium capable of causing a spectrum of illnesses ranging from superficial skin infections to life-threatening endocarditis and sepsis. Central to ...
LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by ...
People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while certain bacteria may help to prevent S. aureus colonisation. These are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results